FDA clearance for BrainLAB's dose algorithm
This article was originally published in Clinica
Executive Summary
The Monte Carlo dose calculation algorithm software developed by BrainLAB has received 510(k) clearance from the US FDA. The device uses the Monte Carlo method, a computational algorithm, to calculate doses of ionising radiation for use in radiosurgery. The software uses a 3D CT-scan of the patient's tissue to create an internal model of the patient and to calculate the dose distribution of the radiation emitted by a linear accelerator. The present implementation is designed to model photon radiation. Westchester, Illinois-based BrainLAB claims that the Monte Carlo algorithm is the "gold standard" for treatment planning accuracy, and contends that its software will help make high-precision treatment available in everyday clinical practice.
You may also be interested in...
ITF Has A Fight On Its Hands In Duchenne
The group’s new muscular dystrophy pill seems unlikely to cut into Sarepta’s sales.
AbbVie Needs To Freshen Up
With half of its 2023 sales coming from aging blockbusters like Humira and Botox, AbbVie needs new blood.
AstraZeneca Pays $2bn To Keep Up With The Joneses
Bristol Myers Squibb and Lilly have recently done billion-dollar radiopharmaceuticals deals, and now the UK group wants a piece of the market. But can it make its Fusion fusion work?